Desiderio Passali
Desiderio Passali is an expert in Otolaryngology at University of Siena (Italy). As of October 2026, ScienceLeadR ranks Desiderio Passali in the top 1% of experts worldwide for Nose Diseases and Rhinitis. Desiderio Passali has authored 340 publications, the most recent in 2026. SLR score: 953 (community average: 125). How the SLR is computed.
LeadR Profile
Otolaryngology
Subspecialties: Pulmonology - Immunology - Pharmacy
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1988 - 2026
Number : 340
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Irreversible Electroporation for Inferior Turbinate Reduction Ablation in Adults. PMID 42817616 — pain, hypersensitivity, hypertrophy, nasal obstruction, morbidity, electroporation | Int Forum Allergy Rhinol | 2026 | 0 |
| Irreversible Electroporation for the Treatment of Pediatric Adenotonsillar Hypertrophy. PMID 42452649 — hemorrhage, tonsillectomy, pain, adenoidectomy, hypertrophy, therapeutics, electroporation, child | J Clin Med | 2026 | 0 |
| Irreversible Electroporation for Tonsillar Ablation in Adults. PMID 42059019 — hemorrhage, tonsillectomy, pain, otolaryngology, electroporation, palatine tonsil | Otolaryngol Head Neck Surg | 2026 | 0 |
| The Diabetic Nose: A Narrative Review of Rhinologic Involvement in Diabetes (1973-2025). PMID 41598409 — diabetes mellitus, rhinitis, nose, sinusitis | J Clin Med | 2026 | 0 |
| HMGB1 as a Key Modulator in Nasal Inflammatory Disorders: A Narrative Review. PMID 40807013 — rhinitis, allergic, glycyrrhizic acid, rhinitis, therapeutics, hmgb1 protein | J Clin Med | 2025 | 0 |
LeadR Networks
Main global connection map